← Open Payments lookup

MILKA NDUNGU: Open Payments

NPI 1538431739 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$560 in 23 payments from 16 companies in 2025. Trend: 2023 $709 · 2024 $876 · 2025 $560

Food & beverage: $560
CompanyPaymentsAmount
Merck Sharp & Dohme LLC3$81
AstraZeneca Pharmaceuticals LP3$74
Mallinckrodt Hospital Products Inc.3$67
Amgen Inc.2$39
Calliditas Therapeutics US Inc.1$35
Otsuka America Pharmaceutical, Inc.1$32
Alnylam Pharmaceuticals Inc.1$30
Veloxis Pharmaceuticals, Inc.1$29
CorMedix Inc.1$25
KYOWA KIRIN, INC.1$25

Products named: PREVYMIS, FARXIGA, ACTHAR, TAVNEOS, TARPEYO, GIVLAARI, ENVARSUS, DEFENCATH.

Industry payments across TX — which companies pay providers there.